Acura Pharmaceuticals Inc (NASDAQ:ACUR)

0.85
Delayed Data
As of Feb 27
 +0.09 / +11.84%
Today’s Change
0.41
Today|||52-Week Range
2.12
+88.89%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Acura Pharmaceuticals Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a +17.65% increase from the last price of 0.85.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Acura Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.09
Sales
$50.0K
Reporting Date
Mar 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -50.00%
 
 
 
 
 
 
Growthannually -6.90%
 
 
 
 
 
 

Sales

Growthquarterly -65.52%
 
 
 
 
 
 
Growthannually 64.23%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account